A pharmaceutical company launching a first-in-class therapy for multiple sclerosis (MS) faced a major challenge: reaching diverse healthcare professional (HCP) audiences across multiple specialties. Each group—neurologists, primary care physicians, and nurses—had distinct information needs, making a one-size-fits-all approach ineffective for education and engagement.